Double Medical Technology Inc.
Symbol: 002901.SZ
SHZ
31.91
CNYTržní cena dnes
214.6551
Poměr P/E
0.2706
Poměr PEG
13.21B
MRK Cap
- 0.00%
Výnos DIV
Double Medical Technology Inc. (002901-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1661 | 1351.3 | 1179.9 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 433.2 | 358.7 | 769.7 | |||||||||||
balance-sheet.row.net-receivables | 0 | 274.3 | 374.5 | 498.1 | |||||||||||
balance-sheet.row.inventory | 0 | 1193.3 | 987.4 | 670.2 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 26.7 | 13 | 46.9 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 3155.3 | 2726.2 | 2395.1 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1070.9 | 877.7 | 698.7 | |||||||||||
balance-sheet.row.goodwill | 0 | 68.3 | 69.1 | 69.7 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 136.9 | 143.2 | 148.6 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 205.2 | 212.3 | 218.3 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 138.9 | 0 | -768.4 | |||||||||||
balance-sheet.row.tax-assets | 0 | 8.9 | 7.2 | 8.3 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 60.6 | 114.3 | 827.9 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1484.4 | 1211.4 | 984.8 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 0 | 4639.7 | 3937.6 | 3379.9 | |||||||||||
balance-sheet.row.account-payables | 0 | 281.6 | 345.4 | 296.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 328 | 7.7 | 5 | |||||||||||
balance-sheet.row.tax-payables | 0 | 4.9 | 31.9 | 99.1 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 261.3 | 60.9 | 13.6 | |||||||||||
Deferred Revenue Non Current | 0 | 50.1 | 48.7 | 48.5 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 372.1 | 226.6 | 7.4 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 275.3 | 114.3 | 69.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 10.9 | 12.9 | 13.6 | |||||||||||
balance-sheet.row.total-liab | 0 | 1429 | 830.9 | 791.5 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 414 | 414 | 405.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | 1275.9 | 1217.3 | 1333.5 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 400.6 | 400.8 | 224.1 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 968 | 968 | 549.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3058.5 | 3000.1 | 2512.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4639.7 | 3937.6 | 3379.9 | |||||||||||
balance-sheet.row.minority-interest | 0 | 102.2 | 106.7 | 75.9 | |||||||||||
balance-sheet.row.total-equity | 0 | 3160.7 | 3106.8 | 2588.4 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 433.2 | 358.7 | 1.3 | |||||||||||
balance-sheet.row.total-debt | 0 | 600.2 | 68.6 | 18.6 | |||||||||||
balance-sheet.row.net-debt | 0 | -627.6 | -924.1 | -391.5 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 59 | 109.2 | 691.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 194.4 | 95.5 | 70.9 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -3.8 | -1.7 | -3.9 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | -606 | 109.6 | 32.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -217.2 | -195 | -134.4 | |||||||||||
cash-flows.row.account-receivables | 0 | 86.8 | 121.9 | -179.4 | |||||||||||
cash-flows.row.inventory | 0 | -422.2 | -418.3 | -140.4 | |||||||||||
cash-flows.row.account-payables | 0 | 118.1 | 103.1 | 189.3 | |||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -1.7 | -3.9 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 659.5 | 10.8 | 16.3 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -305.7 | -285.1 | -235.1 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 1.6 | -0.3 | -88 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -2240.4 | -4523.7 | -6977.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2024.6 | 4992.5 | 6723.4 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -409 | 180.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -519.9 | -225.6 | -396.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -530.5 | -0.7 | -8.3 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 487.5 | 76.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -75.7 | -2.9 | |||||||||||
cash-flows.row.dividends-paid | 0 | -9.4 | -209.4 | -324.1 | |||||||||||
cash-flows.row.other-financing-activites | 0 | -24 | 43.4 | -0.3 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 496.2 | 245.2 | -259.3 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1.1 | 4.3 | -3.6 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 235.2 | 152.3 | 13.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1227.8 | 214.1 | 61.8 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 992.7 | 61.8 | 48.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 85.8 | 128.4 | 673.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -305.7 | -285.1 | -235.1 | |||||||||||
cash-flows.row.free-cash-flow | 0 | -219.9 | -156.6 | 438.2 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1518.8 | 1434.1 | 1994.3 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 527.8 | 333.9 | 311.1 | |||||||||||
income-statement-row.row.gross-profit | 0 | 991 | 1100.2 | 1683.3 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | -43.9 | 25.7 | 19.8 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 983.2 | 984.2 | 865.3 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1511 | 1318.1 | 1176.3 | |||||||||||
income-statement-row.row.interest-income | 0 | 29.9 | 21 | 14.4 | |||||||||||
income-statement-row.row.interest-expense | 0 | 7.2 | 3.1 | 0.5 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 91.9 | 0 | -19.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | -43.9 | 25.7 | 19.8 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | 91.9 | 0 | -19.5 | |||||||||||
income-statement-row.row.interest-expense | 0 | 7.2 | 3.1 | 0.5 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 194.4 | 108.6 | 75.9 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | 7.8 | 147.5 | 822 | |||||||||||
income-statement-row.row.income-before-tax | 0 | 99.7 | 147.5 | 802.5 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 13.4 | 38.2 | 111 | |||||||||||
income-statement-row.row.net-income | 0 | 59 | 92.6 | 673.3 |
Často kladené otázky
Co je Double Medical Technology Inc. (002901.SZ) celková aktiva?
Double Medical Technology Inc. (002901.SZ) celková aktiva jsou 4639740860.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.667.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.212.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.040.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.042.
Co je Double Medical Technology Inc. (002901.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 58972461.000.
Jaký je celkový dluh podniku?
Celkový dluh je 600196725.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 983165028.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.